Literature DB >> 15349109

AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.

Philip I Haigh1, David R Urbach, Lorne E Rotstein.   

Abstract

BACKGROUND: The optimal extent of thyroidectomy for well-differentiated thyroid cancer is controversial. It has been suggested that surgeons use the Age, Metastases, Extent and Size (AMES) risk classification to decide between partial thyroidectomy (PT) or total thyroidectomy (TT).
METHODS: The Surveillance, Epidemiology and End Results database was used to identify patients who underwent PT or TT for well-differentiated thyroid cancer between 1992 and 1997. Age, distant metastases, extrathyroidal extension, tumor size, AMES risk group, gender, histologic subtype, and lymph node metastases were analyzed by using logistic regression models to evaluate whether surgeons use these factors to determine extent of thyroidectomy.
RESULTS: Of 9,226 patients, most patients had small cancers confined to the thyroid gland. Of these, 79.9% were AMES low-risk, and 83% underwent TT. Age 40 years or older (40 to 49 years: odds ratio [OR], 0.75, 95% confidence interval [CI], 0.65 to 0.86; 50 years or older: OR, 0.66; 95% CI, 0.58 to 0.75) was associated with a lower likelihood of TT, as were female gender (OR, 0.80; 95% CI, 0.70 to 0.92) and follicular histology (OR, 0.65; 95% CI, 0.55 to 0.78). Extrathyroidal extension (OR, 3.85; 95% CI, 3.09 to 4.80), regional lymph node metastases (OR, 6.98; 95% CI, 5.45 to 8.93), distant metastases (OR, 7.29; 95% CI, 2.69 to 19.8), AMES high-risk group (OR, 2.82; 95% CI, 2.36 to 3.38), and larger tumor size (OR, 1.27; 95% CI, 1.01 to 1.59) were associated with greater likelihood of TT. In multivariable analyses, only age, extrathyroidal extension, and regional and distant metastases were associated with extent of thyroidectomy; AMES risk group and tumor size were no longer significant.
CONCLUSIONS: Most patients undergo TT for well-differentiated thyroid cancer regardless of AMES risk grouping. In contrast to AMES risk-group classification, younger patients are more likely to undergo TT compared with older patients. Although extrathyroidal extension and distant metastases were associated with TT in accordance with AMES criteria, tumor size had no independent influence. Regional lymph node metastasis, not an AMES criterion, increased the likelihood of TT. Some components of AMES risk-group classification are used by surgeons to choose the extent of thyroidectomy.

Entities:  

Mesh:

Year:  2004        PMID: 15349109     DOI: 10.1016/j.surg.2003.12.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Prognosis of patients with thyroid cancer who do not undergo surgical treatment: a SEER database analysis.

Authors:  Alvaro Sanabria; Luis C Domínguez; Valentín Vega; Camilo Osorio
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

2.  Understanding Malignancies of the Thyroid Gland: Institutional Experience.

Authors:  Jaimanti Bakshi; Sourabha Kumar Patro; Navjot Kaur; Naresh Kumar Panda; Grace Budhiraja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-05

3.  Molecular pathways associated with mortality in papillary thyroid cancer.

Authors:  Naris Nilubol; Chotiya Sukchotrat; Lisa Zhang; Mei He; Electron Kebebew
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

4.  Urokinase-type plasminogen activator and its inhibitor in thyroid neoplasms: a cytosol study.

Authors:  Gordana Horvatić Herceg; Davorin Herceg; Marko Kralik; Zdenka Bence-Zigman; Hrvojka Tomić-Brzac; Ana Kulić
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

5.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

6.  Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease.

Authors:  William D T Kent; Stephen F Hall; Phillip A Isotalo; Robyn L Houlden; Ralph L George; Patti A Groome
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

7.  Risk-stratified management of well-differentiated thyroid cancers: a review of experience from a single institution, 1990-2003.

Authors:  M H Chew; G Chan; M M A Siddiqui; B C Tai; R Sivanandan; K C Soo; D T H Lim
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

Review 8.  A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess.

Authors:  David D Dolidze; Alexey V Shabunin; Robert B Mumladze; Arshak V Vardanyan; Serghei D Covantsev; Alexander M Shulutko; Vasiliy I Semikov; Khalid M Isaev; Airazat M Kazaryan
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

9.  Surgical management for follicular variant of papillary thyroid carcinoma.

Authors:  Jianing Tang; Deguang Kong; Lupin Bu; Gaosong Wu
Journal:  Oncotarget       Date:  2017-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.